Literature DB >> 19115126

Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection.

Negar Khanlou1, David J Moore, Gursharan Chana, Mariana Cherner, Deborah Lazzaretto, Sharron Dawes, Igor Grant, Eliezer Masliah, Ian P Everall.   

Abstract

The frequency of neurodegenerative markers among long surviving human immunodeficiency virus (HIV)-infected individuals is unknown, therefore, the present study investigated the frequency of alpha-synuclein, beta-amyloid, and HIV-associated brain pathology in the brains of older HIV-infected individuals. We examined the substantia nigra of 73 clinically well-characterized HIV-infected individuals aged 50 to 76 years from the National NeuroAIDS Tissue Consortium. We also examined the frontal and temporal cortical regions of a subset of 36 individuals. Neuritic alpha-synuclein expression was found in 16% (12/73) of the substantia nigra of the HIV+cases and none of the older control cases (0/18). beta-Amyloid deposits were prevalent and found in nearly all of the HIV+cases (35/36). Despite these increases of degenerative pathology, HIV-associated brain pathology was present in only 10% of cases. Among older HIV+adults, HIV-associated brain pathology does not appear elevated; however, the frequency of both alpha-synuclein and beta-amyloid is higher than that found in older healthy persons. The increased prevalence of alpha-synuclein and beta-amyloid in the brains of older HIV-infected individuals may predict an increased risk of developing neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115126      PMCID: PMC3979854          DOI: 10.1080/13550280802578075

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  34 in total

1.  Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo.

Authors:  E Masliah; C E Westland; E M Rockenstein; C R Abraham; M Mallory; I Veinberg; E Sheldon; L Mucke
Journal:  Neuroscience       Date:  1997-05       Impact factor: 3.590

2.  Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function.

Authors:  Heather Snyder; Kwame Mensah; Catherine Theisler; Jack Lee; Andreas Matouschek; Benjamin Wolozin
Journal:  J Biol Chem       Date:  2003-01-24       Impact factor: 5.157

3.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

Review 4.  HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Authors:  H Budka; C A Wiley; P Kleihues; J Artigas; A K Asbury; E S Cho; D R Cornblath; M C Dal Canto; U DeGirolami; D Dickson
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

5.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

6.  Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS.

Authors:  S F An; B Giometto; M Groves; R F Miller; A A Beckett; F Gray; B Tavolato; F Scaravilli
Journal:  J Neuropathol Exp Neurol       Date:  1997-11       Impact factor: 3.685

7.  Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.

Authors:  Deborah E Cabin; Kazuhiro Shimazu; Diane Murphy; Nelson B Cole; Wolfram Gottschalk; Kellie L McIlwain; Bonnie Orrison; Amy Chen; Christopher E Ellis; Richard Paylor; Bai Lu; Robert L Nussbaum
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

8.  Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.

Authors:  E Masliah; R K Heaton; T D Marcotte; R J Ellis; C A Wiley; M Mallory; C L Achim; J A McCutchan; J A Nelson; J H Atkinson; I Grant
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

9.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

10.  Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.

Authors:  Steven Paul Woods; Julie D Rippeth; Alan B Frol; Joel K Levy; Elizabeth Ryan; Vicki M Soukup; Charles H Hinkin; Deborah Lazzaretto; Mariana Cherner; Thomas D Marcotte; Benjamin B Gelman; Susan Morgello; Elyse J Singer; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-09       Impact factor: 2.475

View more
  40 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.

Authors:  C Scheller; G Arendt; T Nolting; C Antke; S Sopper; M Maschke; M Obermann; A Angerer; I W Husstedt; F Meisner; E Neuen-Jacob; H W Müller; P Carey; V Ter Meulen; P Riederer; E Koutsilieri
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

3.  Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Young Ahn; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2011-12-09       Impact factor: 3.307

4.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

Review 5.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 6.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 7.  A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Authors:  Norman J Haughey; Xiaomao Zhu; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-08       Impact factor: 4.147

Review 8.  Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 9.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

10.  The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection.

Authors:  Steven Paul Woods; Matthew S Dawson; Erica Weber; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2009-09-17       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.